Medicare Enrolled

Dr. Geeta George, MD

Hematology & Oncology · Peekskill, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2 STOWE RD STE 11, Peekskill, NY 10566
9147347889
In practice since 2006 (19 years)
NPI: 1548344500 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. George from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. George? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. George

Dr. Geeta George is a hematology & oncology specialist in Peekskill, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. George performed 1,067 Medicare services across 275 unique beneficiaries.

Between the years covered by Open Payments, Dr. George received a total of $9,390 from 45 pharmaceutical and/or device companies across 466 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. George is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 40% volume in NY $9,390 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,067
Medicare services
Top 40% in NY for hematology & oncology
275
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~56 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
291 $19 $27
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
289 $80 $112
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
173 $61 $83
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
158 $110 $158
Initial nursing facility care, moderate complexity
Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes.
58 $118 $158
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
48 $155 $270
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
18 $68 $87
New patient office visit, complex (60-74 min) 16 $164 $244
Nursing facility visit, low complexity
A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care.
16 $64 $94
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
43.5% high complexity
0.0% medium
56.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$9,390
Total received (2018-2024)
Avg $1,341/year across 7 years
Top 26% in NY for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
466
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,408 (89.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$982 (10.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,132
2023
$1,944
2022
$1,781
2021
$1,121
2020
$1,095
2019
$1,307
2018
$1,010

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$284
Novartis Pharmaceuticals Corporation
$190
AstraZeneca Pharmaceuticals LP
$185
PFIZER INC.
$151
E.R. Squibb & Sons, L.L.C.
$139
Incyte Corporation
$41
Celgene Corporation
$31
ABBVIE INC.
$23
TAIHO ONCOLOGY, INC.
$22
Stemline Therapeutics Inc.
$17
JAZZ PHARMACEUTICALS INC.
$17
Janssen Pharmaceuticals, Inc
$16
BeiGene USA, Inc.
$15
Top 3 companies account for 58.2% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$1,086
AstraZeneca Pharmaceuticals LP
$1,079
PFIZER INC.
$1,066
Novartis Pharmaceuticals Corporation
$1,000
E.R. Squibb & Sons, L.L.C.
$748
Seagen Inc.
$568
Boehringer Ingelheim Pharmaceuticals, Inc.
$364
Incyte Corporation
$364
Amgen Inc.
$350
Celgene Corporation
$334
AbbVie Inc.
$245
Seattle Genetics, Inc.
$226
Taiho Oncology, Inc.
$205
GENZYME CORPORATION
$176
Merck Sharp & Dohme Corporation
$132
Bayer HealthCare Pharmaceuticals Inc.
$127
Mirati Therapeutics, Inc.
$111
TAIHO ONCOLOGY, INC.
$107
EMD Serono, Inc.
$102
SANOFI-AVENTIS U.S. LLC
$77
Global Blood Therapeutics, Inc.
$75
Pharmacyclics LLC, an AbbVie Company
$69
GlaxoSmithKline, LLC.
$64
Pharmacyclics LLC, An AbbVie Company
$61
Karyopharm Therapeutics Inc.
$51
Dova Pharmaceuticals
$50
Kyowa Kirin, Inc.
$49
Merck Sharp & Dohme LLC
$47
Astellas Pharma US Inc
$43
CTI BioPharma Corp.
$42
Gilead Sciences, Inc.
$39
Daiichi Sankyo Inc.
$38
Stemline Therapeutics Inc.
$35
Blueprint Medicines Corporation
$35
BeiGene USA, Inc.
$30
Alexion Pharmaceuticals, Inc.
$29
ABBVIE INC.
$23
TESARO, Inc.
$22
Clovis Oncology, Inc.
$20
PharmaEssentia USA Corporation
$19
Helsinn Therapeutics (U.S.), Inc.
$18
Immunocore Limited
$17
JAZZ PHARMACEUTICALS INC.
$17
Janssen Pharmaceuticals, Inc
$16
Pharmacosmos Therapeutics Inc.
$15
Top 3 companies account for 34.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · AYVAKIT · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRUKINSA · DARZALEX · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Enhertu · Erleada · Fabhalta · GAVRETO · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LONSURF · LUMAKRAS · LYNPARZA · Lonsurf · MONOFERRIC · Neulasta · Nplate · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Orserdu · PADCEV · PIQRAY · POTELIGEO · PROMACTA · Pomalyst · REBLOZYL · Revlimid · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOLIRIS · SUTENT · Stivarga · TAGRISSO · TECVAYLI · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Trodelvy · VENCLEXTA · Vonjo · XALKORI · XARELTO · XPOVIO · XTANDI · Xofigo · ZEJULA · ZEPZELCA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Peekskill?
Compare hematology & oncology specialists in the Peekskill area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
84
Per 100K population
8.4
County median income
$118,411
Nearest hospital
HUDSON VALLEY HOSPITAL CENTER
1.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. George is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. George experienced with additional hour of intravenous infusion?
Based on Medicare claims data, Dr. George performed 291 additional hour of intravenous infusion services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. George receive payments from pharmaceutical companies?
Yes. Dr. George received a total of $9,390 from 45 companies across 466 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. George's costs compare to other hematology & oncology specialists in Peekskill?
Dr. George's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. George) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →